Latest Share Purchase Plan News

Talga Group has lodged a detailed prospectus for issuing attaching and piggyback options to recent Placement and Share Purchase Plan participants, potentially raising up to A$32.7 million upon exercise. The move supports its battery anode production scale-up and international expansion plans.

Andean Silver reports robust drilling results at its Cerro Bayo Silver-Gold Project in Chile, revealing significant mineralisation expansions and upgrades ahead of a resource update. The findings underpin ongoing restart studies and feasibility work, supported by strong funding and rising precious metals prices.

Kalamazoo Resources has successfully closed an oversubscribed Share Purchase Plan, raising $4.1 million to fast-track drilling and development at its Ashburton Gold Project. Combined with a recent placement, the company secures $12.1 million to advance exploration and pre-feasibility studies.

Cannindah Resources has announced a two-tranche placement raising approximately $15 million and a concurrent Share Purchase Plan offering eligible shareholders the chance to invest up to $30,000 at a discounted price. The funds will support drilling and exploration at the Mt Cannindah Copper-Gold Project.

Lotus Resources has completed a A$76 million placement to bolster its financial position as it accelerates uranium production at the Kayelekera Mine, aiming for steady state output and first shipments in Q2 2026.

Lotus Resources has launched a A$81 million equity raising to support the ramp-up of its Kayelekera uranium mine to steady state production targeted in Q2 2026, while advancing development of its Letlhakane project.

Lotus Resources has launched a A$76 million placement alongside a A$5 million share purchase plan to fund the ramp-up of uranium production at its Kayelekera mine, aiming for steady-state output by mid-2026 amid strong market fundamentals.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

Cannindah Resources has raised $15 million through a two-tranche placement and launched a $2 million share purchase plan to fund expanded exploration at its Mt Cannindah Copper-Gold Project.

Actinogen Medical has raised approximately $17 million through a share placement and purchase plan to fund the completion of its pivotal XanaMIA Alzheimer’s trial following encouraging interim results.

Brightstar Resources has successfully raised $180 million through a $175 million institutional placement and a $5 million share purchase plan, fully funding its Goldfields development and advancing the Sandstone project towards a final investment decision.

TradeWindow Holdings Limited has announced a share purchase plan to raise up to NZ$1 million by issuing new shares to eligible New Zealand and Australian shareholders, opening on 2 February 2026.